{ "cik": 1347178, "cik_padded": "0001347178", "entityName": "Vanda Pharmaceuticals Inc.", "fiscal_years": [ { "accn": "0001628280-26-007460", "filed": "2026-02-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 998000.0, "cash": 84851000.0, "eps_diluted": -3.74, "free_cash_flow": -110440000.0, "net_income": -220474000.0, "operating_cash_flow": -109442000.0, "operating_income": -151168000.0, "revenue": 216105000.0, "stockholders_equity": 327186000.0, "total_assets": 488948000.0, "total_liabilities": 161762000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.49440379478339536, "net_margin": -1.0202170241317878, "operating_margin": -0.6995118113879826, "revenue_growth_yoy": 0.08720041052059646, "roa_avg2y": -0.38505630693567316, "roa_period_end": -0.4509150257287074, "roe_avg2y": -0.5093354525418952, "roe_period_end": -0.6738491255738326 } }, { "accn": "0001628280-26-007460", "filed": "2026-02-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 490000.0, "cash": 102316000.0, "eps_diluted": -0.33, "free_cash_flow": -16247000.0, "net_income": -18900000.0, "operating_cash_flow": -15757000.0, "operating_income": -40660000.0, "revenue": 198772000.0, "stockholders_equity": 538546000.0, "total_assets": 656204000.0, "total_liabilities": 117658000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2184734451653155, "net_margin": -0.09508381462177772, "operating_margin": -0.2045559736783853, "revenue_growth_yoy": 0.03183139534883721, "roa_avg2y": -0.028973421101848473, "roa_period_end": -0.028802018884371325, "roe_avg2y": -0.03488835725677831, "roe_period_end": -0.0350944951777564 } }, { "accn": "0001628280-26-007460", "filed": "2026-02-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 383000.0, "cash": 135821000.0, "eps_diluted": 0.04, "free_cash_flow": 12418000.0, "net_income": 2509000.0, "operating_cash_flow": 12801000.0, "operating_income": -13952000.0, "revenue": 192640000.0, "stockholders_equity": 544910000.0, "total_assets": 648440000.0, "total_liabilities": 103530000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18999467802022352, "net_margin": 0.013024294019933555, "operating_margin": -0.07242524916943521, "revenue_growth_yoy": -0.24271371402064612, "roa_avg2y": 0.003912100146021594, "roa_period_end": 0.0038692862870890136, "roe_avg2y": 0.004680498606483675, "roe_period_end": 0.004604430089372557 } }, { "accn": "0001628280-26-007460", "filed": "2026-02-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 679000.0, "cash": 135029000.0, "eps_diluted": 0.11, "free_cash_flow": 31305000.0, "net_income": 6275000.0, "operating_cash_flow": 31984000.0, "operating_income": 6329000.0, "revenue": 254382000.0, "stockholders_equity": 527198000.0, "total_assets": 634247000.0, "total_liabilities": 107049000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20305274299219647, "net_margin": 0.024667625854030553, "operating_margin": 0.024879905024726593, "revenue_growth_yoy": -0.053222768923857945, "roa_avg2y": 0.01021954514473889, "roa_period_end": 0.009893621885479946, "roe_avg2y": 0.012159368139161304, "roe_period_end": 0.011902548947454277 } }, { "accn": "0001628280-25-005761", "filed": "2025-02-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 552000.0, "cash": 52071000.0, "eps_diluted": 0.58, "free_cash_flow": 63662000.0, "net_income": 33152000.0, "operating_cash_flow": 64214000.0, "operating_income": 42165000.0, "revenue": 268682000.0, "stockholders_equity": 504928000.0, "total_assets": 593792000.0, "total_liabilities": 88864000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17599340896127766, "net_margin": 0.12338749897648521, "operating_margin": 0.1569327308863266, "revenue_growth_yoy": 0.08266174526933368, "roa_avg2y": 0.05881935474713639, "roa_period_end": 0.05583099805992671, "roe_avg2y": 0.06919684322798932, "roe_period_end": 0.06565688573420368 } }, { "accn": "0001628280-24-003785", "filed": "2024-02-08", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1795000.0, "cash": 61031000.0, "eps_diluted": 0.42, "free_cash_flow": 49980000.0, "net_income": 23337000.0, "operating_cash_flow": 51775000.0, "operating_income": 27239000.0, "revenue": 248168000.0, "stockholders_equity": 453266000.0, "total_assets": 533456000.0, "total_liabilities": 80190000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17691598310925594, "net_margin": 0.09403710389735984, "operating_margin": 0.1097603236517198, "revenue_growth_yoy": 0.09234642674789162, "roa_avg2y": 0.04588460131890948, "roa_period_end": 0.043746813232956414, "roe_avg2y": 0.054007643966577604, "roe_period_end": 0.05148632370396191 } }, { "accn": "0001628280-23-002857", "filed": "2023-02-09", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1019000.0, "cash": 45072000.0, "eps_diluted": 2.11, "free_cash_flow": 44928000.0, "net_income": 115553000.0, "operating_cash_flow": 45947000.0, "operating_income": 22810000.0, "revenue": 227188000.0, "stockholders_equity": 410945000.0, "total_assets": 483748000.0, "total_liabilities": 72803000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17715996057866623, "net_margin": 0.5086228145852774, "operating_margin": 0.10040142965297463, "revenue_growth_yoy": 0.17642063401650804, "roa_avg2y": 0.28326048747484306, "roa_period_end": 0.23887023822320713, "roe_avg2y": 0.336709078379351, "roe_period_end": 0.2811884802102471 } }, { "accn": "0001628280-22-003629", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 368000.0, "cash": 61005000.0, "eps_diluted": 0.48, "free_cash_flow": 29618000.0, "net_income": 25208000.0, "operating_cash_flow": 29986000.0, "operating_income": 21738000.0, "revenue": 193118000.0, "stockholders_equity": 275422000.0, "total_assets": 332130000.0, "total_liabilities": 56708000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20589495392524926, "net_margin": 0.13053159208359655, "operating_margin": 0.11256330326536107, "revenue_growth_yoy": 0.16982366445969604, "roa_avg2y": 0.09378761243035597, "roa_period_end": 0.07589799175021829, "roe_avg2y": 0.12393039485360452, "roe_period_end": 0.09152500526464843 } }, { "accn": "0001347178-21-000005", "filed": "2021-02-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1664000.0, "cash": 33627000.0, "eps_diluted": -0.35, "free_cash_flow": -3647000.0, "net_income": -15567000.0, "operating_cash_flow": -1983000.0, "operating_income": -16903000.0, "revenue": 165083000.0, "stockholders_equity": 131387000.0, "total_assets": 205425000.0, "total_liabilities": 74038000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5635108496274365, "net_margin": -0.09429801978398747, "operating_margin": -0.10239091850765979, "revenue_growth_yoy": 0.13057383729291794, "roa_avg2y": -0.07487752495797248, "roa_period_end": -0.07577948156261409, "roe_avg2y": -0.11850774788079949, "roe_period_end": -0.11848204160228942 } }, { "accn": "0001347178-20-000003", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1407000.0, "cash": 40426000.0, "eps_diluted": -0.41, "net_income": -18010000.0, "operating_income": -18571000.0, "revenue": 146017000.0, "stockholders_equity": 131330000.0, "total_assets": 210374000.0, "total_liabilities": 79044000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6018731439884261, "net_margin": -0.12334180266681277, "operating_margin": -0.12718382106193116, "roa_period_end": -0.08560943842870315, "roe_period_end": -0.13713546029087031 } }, { "accn": "0001193125-14-066051", "filed": "2014-02-25", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -39592000.0 }, "period_end": "2013-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-007460", "filed": "2026-02-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001347178.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001347178.json" }, "ticker": "VNDA" }